Flagship Harbor Advisors LLC Has $1.64 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Flagship Harbor Advisors LLC grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 96.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,192 shares of the exchange traded fund’s stock after purchasing an additional 8,938 shares during the period. Flagship Harbor Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,638,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund grew its stake in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $141,284,000. Assetmark Inc. increased its holdings in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares in the last quarter. Sivik Global Healthcare LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $29,640,000. Finally, Mirae Asset Securities USA Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.6 %

SPDR S&P Biotech ETF stock opened at $92.46 on Monday. The stock has a 50-day simple moving average of $93.34 and a 200 day simple moving average of $96.90. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.